Takeda Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
145
- Portfolio
-
37
- Exits
-
70
Takeda Ventures General Information
Company Description
Founded in 2001, Takeda Ventures is a corporate venture capital arm of Takeda Pharmaceutical Company Limited, based in Cambridge, Massachusetts. The firm prefers to invest in oncology, rare genetics & hematology, neuroscience, and the gastrointestinal and inflammation sectors.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- 500 Kendall Street
- Cambridge, MA 02142
- United States
Takeda Ventures Investments (145)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Oryon Cell Therapies | 09-Mar-2026 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Integra Therapeutics | 08-Sep-2025 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Degron Therapeutics | 22-Jan-2025 | Drug Discovery | Generating Revenue | |||
| Harness Therapeutics | 20-Jan-2025 | Biotechnology | Pre-Clinical Trials | |||
| Be Biopharma | 01-Oct-2024 | Drug Discovery | Out of Business | |||
| Accipiter Biosciences | 17-May-2024 | Biotechnology | Pre-Clinical Trials | |||
| Cerevance | 13-Mar-2024 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Harness Therapeutics | 01-Dec-2023 | Biotechnology | Pre-Clinical Trials | |||
| EvolveImmune Therapeutics | 16-Nov-2023 | Early Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| Larkspur Biosciences | 23-May-2023 | Early Stage VC | Drug Delivery | Generating Revenue |
Takeda Ventures Exits (70)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Be Biopharma | 05-Oct-2026 | Out of Business | |
| Obsidian Therapeutics | 03-Aug-2026 | ||
| Univercells | 25-Jun-2026 | ||
| Shattuck Labs | 11-Jun-2026 | ||
| Certa Therapeutics | 01-Mar-2026 | ||
| Gliknik | 01-Feb-2026 | ||
| Ramino-Bio | 08-Aug-2025 | ||
| Abintus Bio | 15-Jul-2025 | ||
| HC Bioscience | 18-Mar-2025 | Out of Business | |
| Zelluna | 17-Dec-2024 | Reverse Merger |
Takeda Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Takeda Ventures Co-Investors (103)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| ARCH Venture Partners | 3 |
|
|
||
| Alexandria Venture Investments |
|
|
|||
| Bristol-Myers Squibb |
|
|
|||
| Qatar Investment Authority |
|
|
|||
| SV Health Investors |
|
|
Takeda Ventures FAQs
-
What is Takeda Ventures?
Founded in 2001, Takeda Ventures is a corporate venture capital arm of Takeda Pharmaceutical Company Limited, based in Cambridge, Massachusetts.
-
When was Takeda Ventures founded?
Takeda Ventures was founded in 2001.
-
Where is Takeda Ventures headquartered?
Takeda Ventures is headquartered in Cambridge, MA.
-
How many investments has Takeda Ventures made?
Takeda Ventures has made 145 investments.
-
What has Takeda Ventures invested in?
Takeda Ventures has made numerous investments in companies like Oryon Cell Therapies, Integra Therapeutics, and Degron Therapeutics within the Drug Discovery and Discovery Tools (Healthcare) industries.
-
What has Takeda Ventures invested in recently?
Takeda Ventures's latest investment was on 09-Mar-2026 in Oryon Cell Therapies, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
